BIOYGraniteShares YieldBOOST Biotech ETF
Get income#1634 of 1645 for Get income
The Fund’s primary investment objective is to achieve 3 times (300%) the income generated from selling options on the S&P Biotechnology Select Industry Index by selling options on leveraged ETFs.
Annual Cost
0.00%
#5378 out of 5,378 ETFs
Fund Size
—
#5378 out of 5,378 ETFs
Dividend Yield
—
Track Record
—
#5378 out of 5,378 ETFs
Performance
1 Year
N/A
3 Years
N/A
5 Years
N/A
What's inside
Asset class
Region
Strategy
option income
Risk profile
Volatility (1Y)
N/A
Max drawdown
-0.7%
Worst peak-to-trough loss
Sharpe (3Y)
N/A
Sortino (3Y)
N/A
Similar ETFs
Data updated on 2026-05-09